A scent of citrus: could bitter orange oil ease fatigue and aid sleep in diabetes?
NCT ID NCT07756151
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This trial tests whether inhaling bitter orange oil before bed can improve sleep quality and reduce fatigue in adults with type 2 diabetes. One hundred participants will be randomly assigned to inhale either bitter orange oil or plain water for three nights. On the fourth morning, researchers will measure sleep quality, fatigue levels, and blood sugar to see if the citrus scent makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bitter orange oil inhalation aromatherapy
- What this could lead to
- If effective, this simple, drug-free aromatherapy could offer a low-cost way to help people with type 2 diabetes sleep better and feel less tired.
- What could go wrong
- This is a small, short-term trial (three nights) with a subjective outcome. Results may not apply broadly, and the effect could be due to placebo or the ritual of inhalation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your gut bacteria hold the key to protecting your kidneys?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect
- Can diabetes disrupt the Brain-Heart link?
- Gut bacteria swap may tame diabetes and thyroid disease
- A blood marker may reveal how well diabetes treatments are working
- A simple phone call may help millions with diabetes manage insulin — a trial puts it to the test